Ongoing Psychiatric Medication Management: Visit Frequency, Monitoring and Your Role

Ongoing psychiatric medication management means regular follow-up visits with a prescriber to check how a medication is working, catch side effects early, run any needed lab or heart tests, and adjust the plan. Visits are usually closer together when you start or change a medication and spread out once you are stable. Your part is to take medications as agreed, track how you feel, and tell your prescriber about every supplement and change in your health.

This article covers the rhythm of visits, what gets monitored for common medication types, and how to make each appointment count. For the bigger picture of how a medication plan is built, see the practice's patient's guide to medication management.

How often you will be seen

There is no single schedule. Frequency depends on the medication, your diagnosis, how severe your symptoms are, and how recently anything changed. A common general pattern looks like this:

• Starting or changing a medication: follow-up within a few weeks, sometimes sooner, to check early side effects and response.
• Adjusting the dose: visits every few weeks until the dose is settled.
• Stable on a working regimen: visits spaced out, often every few months.
• Any time between visits: a portal message or call if side effects, worsening mood or a new medical issue appears.

Spacing out visits is a sign of stability, not of less care. A stable patient still needs periodic review, because life changes, other medications get added, and the reasons for a medication can fade over time. Ask your prescriber what schedule they recommend for you and what would prompt them to see you sooner.

Some situations call for closer contact regardless of stage: new or worsening suicidal thoughts, signs of mania, pregnancy, a serious medical illness, or starting a medication that needs blood levels. For antidepressants, FDA labeling directs prescribers to closely monitor all patients for clinical worsening and the emergence of suicidal thoughts and behaviors, and the boxed warning highlights children and young adults.

If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

What gets checked at a typical follow-up

1. Symptoms, often with a standard rating scale so changes are measured over time.
2. Side effects, asked about directly: sleep, appetite, weight, sexual function, energy, restlessness, emotional flatness.
3. How you are actually taking the medication, including missed doses and timing.
4. New prescriptions, over-the-counter drugs, supplements, alcohol and cannabis.
5. Physical health changes, including pregnancy plans.
6. Whether the current plan still matches your goals.

Expect your prescriber to also review vital signs or weight when relevant, and to order labs on the schedule the medication requires.

Monitoring for specific medication types

Some psychiatric medications need little routine testing. Others have specific monitoring set out in FDA labeling or guidelines. The table summarizes the main ones; your prescriber will tailor it to you.

Antipsychotic metabolic monitoring

In 2004, the American Diabetes Association and the American Psychiatric Association, with endocrinology and obesity organizations, published a consensus statement on antipsychotic drugs, obesity and diabetes that set out a metabolic monitoring protocol. The ADA's 2025 Standards of Care, citing that consensus, say that people with schizophrenia and related conditions who take antipsychotics should have body weight, glucose and lipids monitored every 12 to 16 weeks, unless clinical circumstances call for sooner checks. The same medications are also prescribed for depression and bipolar disorder, and their labels call for checking fasting glucose and lipids before or soon after starting and periodically afterward, whatever the reason they are prescribed.

Lithium

Lithium can be very effective, and its safety depends on monitoring. The label calls for evaluating kidney function, vital signs, electrolytes, thyroid function, other medications and pregnancy status before treatment, monitoring thyroid function regularly, and monitoring calcium because of a link to high calcium and parathyroid problems with long-term use. Blood samples for lithium levels are drawn just before the next dose. Diuretics, NSAID pain relievers and some blood pressure medications can raise lithium levels, so tell every clinician you take it.

Controlled medications

Before prescribing a Schedule II, III or IV controlled substance, such as a stimulant or benzodiazepine, every New York practitioner must consult the state prescription monitoring program registry, with limited exceptions. Expect this to happen routinely. It protects you as well as the prescriber.

Stimulants for ADHD

In 2023 the FDA required the boxed warning for all prescription stimulants to describe the risks of misuse, abuse, addiction and overdose, and asked prescribers to assess each patient's risk before prescribing and to keep monitoring throughout treatment. Stimulant labels also call for checking for heart disease before starting, through a careful history, family history and physical exam, and for monitoring blood pressure and pulse during treatment. In children, growth in height and weight is monitored closely. ADHD medication and your heart explains what those checks involve and which readings prompt a change.

Lamotrigine

Lamotrigine, FDA-approved for maintenance treatment of bipolar I disorder, carries a boxed warning for serious skin rashes, including Stevens-Johnson syndrome. Missed doses matter too: the label says that if lamotrigine has been stopped for more than five half-lives, the initial dosing recommendations should be followed when restarting. If you have missed several days, contact your prescriber before taking your next dose rather than resuming your usual amount. Lithium vs lamotrigine compares the two maintenance options.

Clozapine

Clozapine has long required regular blood counts. In February 2025 the FDA told manufacturers that the clozapine REMS program must be eliminated, but it still recommends that prescribers monitor patients' absolute neutrophil count according to the frequencies in the prescribing information. In practice, the blood tests continue.

Movement side effects with antipsychotics

Antipsychotics can cause tardive dyskinesia, a syndrome of potentially irreversible involuntary movements. The label notes that the risk appears to rise with duration of treatment and cumulative dose, but that it can also develop after relatively brief treatment at low doses. Mention any new twitching, lip smacking or restless movements at your next visit, or sooner. More detail on weight, glucose and lipid checks is in antipsychotics and metabolic health, and lithium blood levels are covered in taking lithium: blood levels, kidney and thyroid monitoring.

How integrative practices add to standard monitoring

An integrative approach keeps all of the required safety monitoring and adds a wider view. That may include reviewing basic labs that affect mood and energy, such as thyroid function, vitamin D, B12, iron and blood sugar; looking at sleep, movement, nutrition and alcohol; and checking whether supplements are helping, doing nothing, or interacting with prescriptions.

The aim is to see whether lifestyle changes can support lower doses or fewer medications over time, without dropping safety checks. Any reduction should be gradual and supervised (see tapering psychiatric medication with support).

How medication changes are usually made

Careful prescribers tend to change one thing at a time. If a dose goes up and a new medication starts in the same week, neither you nor your prescriber can tell which caused a new side effect or an improvement. Changes are usually made in steps, with time between them to judge the effect.

Before any change, it helps to agree on three things: what the change is meant to fix, what side effects to watch for in the first days and weeks, and when you will check in. Ask for written instructions if a schedule is involved, such as a cross-taper from one antidepressant to another. If something feels wrong after a change, contact your prescriber rather than reversing it yourself.

Making each visit count is simple but often skipped. Send your log or a short update before the appointment if the practice allows it. Lead with the most important issue rather than saving it for the last minute. Before you leave, repeat back the plan: what stays the same, what changes, and when the next contact is.

Prescriptions, refills and pharmacies

Much of the friction in ongoing medication care is logistical. A few rules explain most of it.

• Prescriptions in New York are electronic. State law requires prescriptions issued in New York to be made electronically, with limited exceptions such as a temporary technical failure or a waiver. If you change pharmacies, tell your prescriber so the next prescription goes to the right place.
• Schedule II medications cannot be refilled. That includes most stimulants. Under federal rules, a prescriber may instead issue several prescriptions at once covering up to a 90-day supply, each with the earliest date it may be filled, when the prescriber judges it safe and state law allows it.
• The prescription monitoring registry is checked routinely. In New York, prescribers consult it before prescribing Schedule II, III or IV medications.
• Insurance may require prior authorization for some medications or doses, which can add days. Prior authorization for psychiatric medications explains how to move it along.
• Costs can often be lowered by switching pharmacies, formulations or to a generic. See lowering prescription costs and generic vs brand-name psychiatric medications.

Ask for refills when you have about a week left, not on the last day. If your pharmacy cannot fill a stimulant because of supply problems, what to do if your pharmacy is out covers the options.

Questions to ask when a new medication starts

The first visit after a prescription is written sets up everything that follows. Before you leave, it helps to have answers to these questions, ideally in writing:

1. What is this medication meant to change, and how will we measure it?
2. How long until we would expect to see a benefit, and when will we decide whether it is working?
3. Which side effects are common and usually fade, and which should I report right away?
4. Does it need any blood tests, heart checks or blood pressure readings, and when?
5. Does it interact with anything I already take, including supplements and alcohol?
6. What should I do if I miss a dose, or several?
7. If I want to stop one day, how would we do it safely?
8. How do I reach you between visits, and what counts as urgent?

Medication guides from the pharmacy answer some of these, but your prescriber can tell you which points matter for you.

Your role between visits

You see yourself every day; your prescriber sees a snapshot. These habits make the snapshot accurate:

• Keep a simple log: mood, sleep, energy, anxiety and side effects, a line or two a day or a few times a week.
• Take medications as agreed. If you miss doses or want to stop, say so. Do not stop or change a medication on your own; some cause withdrawal symptoms or relapse if stopped suddenly.
• Report every supplement, herbal product and over-the-counter medicine. St. John's wort, for example, is listed on SSRI labels among products that raise the risk of serotonin syndrome.
• Get labs done on time, and ask for results to be sent to your prescriber.
• Tell your prescriber about pregnancy plans, new diagnoses and new prescriptions from other doctors.
• Bring your top two or three questions to each visit.

If you are new to a practice, preparing your medication history helps the first visits go faster.

A simple log to bring to each visit

A one-page log turns "I think it's a bit better" into something you and your prescriber can act on. Fill in one row a week, or one a day during a medication change, and rate mood and anxiety on the same simple scale each time.

If your prescriber uses standard questionnaires, such as the PHQ-9 for depression or the GAD-7 for anxiety, keep your scores with the log. PHQ-9 and GAD-7 scores explained shows what the numbers mean and why a trend matters more than a single result.

Situations that change the monitoring plan

• Pregnancy or planning one. Tell your prescriber before you try to conceive if you can, since some medications need a different plan and stopping suddenly carries its own risks. See psychiatric medications during pregnancy.
• Drinking alcohol. Alcohol interacts with a number of psychiatric medications, and some combinations are risky. Be candid about how much you drink; psychiatric medications and alcohol explains why.
• A new prescription from another doctor. Antibiotics, pain relievers, blood pressure medicines and others can change how psychiatric medications work, as with NSAIDs and some blood pressure drugs raising lithium levels. Ask every prescriber to check, and make sure your primary care doctor and psychiatrist share information; how your psychiatrist and primary care doctor should work together covers the handoffs.
• Switching medications. A cross-taper or washout usually needs closer contact for a few weeks; switching antidepressants explains the common approaches.
• Moving to telehealth. Much follow-up can happen by video, but labs still need an in-person step, and blood pressure and weight need a reliable reading at home or in an office; telehealth vs in-person psychiatry sets out the tradeoffs.

When to ask for more than routine follow-up

Ask for an earlier visit if symptoms are worse, side effects are hard to tolerate, or something in your life has changed significantly. If the plan is not working after a fair trial, it is reasonable to ask for a change in approach or an outside opinion (see signs your treatment isn't working and getting a second opinion). For who should prescribe in the first place, see psychiatrist or primary care for antidepressants. All of the guides are listed in the choosing psychiatric care guide.

Bringing your therapist and other clinicians in

Medication management works better when the people who see you most often can share what they notice. A therapist who sees you weekly may spot early signs of improvement, a side effect or a relapse before a prescriber who sees you every few months. With your written permission, the two can exchange brief updates, especially around medication changes. If you already have a therapist outside the practice, keeping your therapist while seeing an integrative psychiatrist explains how that coordination is usually set up.

When the goal is to reduce or stop

Many people hope to take less medication over time, and that is a reasonable goal to raise. It works best as a planned project rather than a quiet decision: agree on why now is a good time, which medication to change first, how fast to go, what early warning signs of relapse look like for you, and what happens if they appear. Labels for antidepressants such as sertraline recommend gradual dose reduction rather than abrupt stopping, and closer contact during a taper helps catch problems early. If you are unsure whether your current plan is still the right one, getting a second opinion on your psychiatric medication is a reasonable step before making changes.

How this practice handles it

The practice's ongoing care includes psychiatric evaluation and medication management, psychotherapy, coaching, lab testing, and nutrition and lifestyle psychiatry. The practice's prescribers include psychiatrists and psychiatric nurse practitioners. Lab and supplement costs are separate from visit fees. All of the practice's practitioners are out of network with all insurance plans, and payment is due at the time of service; the practice provides a superbill after each session that you can submit to your insurer for possible out-of-network reimbursement. Current fees are on the insurance and payment page. You can read about the approach on the medication management page and start with a free discovery call, where the team answers questions about care options, scheduling and insurance.

Frequently asked questions

How long are medication management visits?

It varies by practice and by stage of treatment. First evaluations are usually much longer than follow-ups. Ask the practice how long each visit type is before you book.

Can medication management be done by telehealth?

Often, yes, as long as the prescriber is licensed in the state where you are located during the visit. Some monitoring, such as blood tests or blood pressure checks, still needs an in-person step.

Will I need medication management forever?

Not necessarily. Some people take medication for a defined period and then taper with supervision; others benefit from longer treatment. The decision is made with your prescriber based on your history and how you are doing.

What if I can't afford all the recommended labs?

Tell your prescriber. They can explain which tests are required for safety and which are optional, and some tests may be covered by your insurance through your primary care doctor.

Should I bring my therapist into medication decisions?

It often helps. With your permission, your prescriber and therapist can share observations so changes in mood or side effects are noticed sooner.

Why can't my stimulant prescription just be refilled?

Most ADHD stimulants are Schedule II controlled substances, and federal rules prohibit refills of Schedule II prescriptions. Your prescriber can issue a new prescription, or in some cases several dated prescriptions covering up to a 90-day supply, if they judge it safe and state law allows.

I missed several days of my medication. Should I just restart?

Call your prescriber first. For some medications, such as lamotrigine, restarting at your usual dose after a long gap can be risky, and the label calls for starting again at the initial dose after a long enough break. For others, missed doses can cause withdrawal symptoms that your prescriber can help with.

Does clozapine still need regular blood tests?

Yes. The FDA told manufacturers in February 2025 that the clozapine REMS program must be eliminated, but it still recommends monitoring absolute neutrophil counts on the schedule in the prescribing information.

Sources

1. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (American Diabetes Association; American Psychiatric Association; AACE; NAASO), 2004. pubmed.ncbi.nlm.nih.gov
2. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care (American Diabetes Association Professional Practice Committee), 2025. pmc.ncbi.nlm.nih.gov
3. Lithium carbonate prescribing information. U.S. Food and Drug Administration / DailyMed, 2026. dailymed.nlm.nih.gov
4. DEPAKOTE (divalproex sodium) prescribing information. U.S. Food and Drug Administration / DailyMed, 2026. dailymed.nlm.nih.gov
5. CELEXA (citalopram) prescribing information. U.S. Food and Drug Administration / DailyMed, 2023. dailymed.nlm.nih.gov
6. New York Public Health Law § 3343-A: Prescription monitoring program registry. New York State Senate (Open Legislation), 2026. nysenate.gov
7. ZOLOFT (sertraline) prescribing information. U.S. Food and Drug Administration / DailyMed, 2023. dailymed.nlm.nih.gov
8. Rexulti (brexpiprazole) prescribing information. DailyMed / U.S. FDA label, 2026. dailymed.nlm.nih.gov
9. FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions. U.S. Food and Drug Administration (Drug Safety Communication), 2023. fda.gov
10. VYVANSE (lisdexamfetamine dimesylate) prescribing information (revised 04/2026). DailyMed / U.S. FDA label, 2026. dailymed.nlm.nih.gov
11. LAMICTAL (lamotrigine) prescribing information. DailyMed / U.S. FDA label, 2026. dailymed.nlm.nih.gov
12. Information on Clozapine. U.S. Food and Drug Administration, 2025. fda.gov
13. 21 CFR 1306.12: Refilling prescriptions; issuance of multiple prescriptions. Electronic Code of Federal Regulations (DEA), 2026. ecfr.gov
14. New York Public Health Law § 281: Official New York state prescription forms (electronic prescribing). New York State Senate (Open Legislation), 2026. nysenate.gov

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.